Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Cash from Financing Activities (2024 - 2025)

Historic Cash from Financing Activities for Kairos Pharma (KAPA) over the last 2 years, with Q2 2025 value amounting to $223000.0.

  • Kairos Pharma's Cash from Financing Activities rose 4966.44% to $223000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $8.4 million, marking a year-over-year change of. This contributed to the annual value of $5.1 million for FY2024, which is 130800.0% up from last year.
  • As of Q2 2025, Kairos Pharma's Cash from Financing Activities stood at $223000.0, which was up 4966.44% from $3.1 million recorded in Q1 2025.
  • In the past 5 years, Kairos Pharma's Cash from Financing Activities registered a high of $5.2 million during Q3 2024, and its lowest value of -$142000.0 during Q4 2024.